Replies to post #11160 on Momenta Pharmaceuticals, Inc. (MNTA)

[jmkobers]

Why? Wouldn't it still put MNTA close to cash flow neutral annually?

What were you thinking, 10-12 range? Lower?

[jbog]

I would expect the share price to go down significantly with a simultaneous approval.

Polly, this is going to surprise you but I wholeheartedly disagree. I think Momenta will get a nice bump with simultaneous approval or a massive move upon sole approval or rejection.